Cellumed Co.,Ltd. (KOSDAQ:049180)
South Korea · Delayed Price · Currency is KRW 1,009.00
-101.00 (-9.10%)
At close: Mar 16, 2026
Cellumed Market Cap
Cellumed has a market cap or net worth of 83.94 billion as of May 20, 2026. Its market cap has decreased by -19.52% in one year.
Market Cap
83.94B
Enterprise Value
91.55B
Revenue
140.19B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,009.00
Market Cap Chart
Since February 23, 2010, Cellumed's market cap has increased from 69.71B to 83.94B, an increase of 20.41%. That is a compound annual growth rate of 1.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 83.94B | 32.38% |
| Dec 30, 2025 | 63.41B | -51.53% |
| Dec 30, 2024 | 130.83B | 42.19% |
| Dec 28, 2023 | 92.01B | -49.32% |
| Dec 29, 2022 | 181.55B | -31.57% |
| Dec 30, 2021 | 265.31B | 42.94% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The LEADCORP | 85.28B |
| Lion Chemtech | 85.06B |
| Hyundai Industrial | 85.04B |
| DEEPNOID | 85.03B |
| Remed | 84.38B |
| PanGen Biotech | 84.34B |
| Insung Information | 84.28B |
| Yangjisa | 84.06B |